The anti CD47 drugs market is estimated to be valued at USD 0.20 Bn in 2025 and is expected to reach USD 2.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 43.1% from 2025 to 2032. https://www.zupyak.com/p/4605950/t/anti-cd47-drugs-market-forecast-and-strategic-insights